Chantal Himberlin

1.4k total citations
19 papers, 381 citations indexed

About

Chantal Himberlin is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Chantal Himberlin has authored 19 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Oncology. Recurrent topics in Chantal Himberlin's work include Acute Myeloid Leukemia Research (14 papers), Acute Lymphoblastic Leukemia research (6 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Chantal Himberlin is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Acute Lymphoblastic Leukemia research (6 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Chantal Himberlin collaborates with scholars based in France and United States. Chantal Himberlin's co-authors include Sophie Tassan‐Mangina, Pierre Nazeyrollas, Bruno M. Costa, J Elaerts, Christelle Jouannaud, Alain Blaise, Jean‐Luc Harousseau, Norbert Ifrah, Bruno Lioure and Arnaud Pigneux and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Haematologica.

In The Last Decade

Chantal Himberlin

18 papers receiving 375 citations

Peers

Chantal Himberlin
Bita Fakhri United States
J. Radke Germany
DC Jr Case United States
Samuel R. Olson United States
Chantal Himberlin
Citations per year, relative to Chantal Himberlin Chantal Himberlin (= 1×) peers Erica Finolezzi

Countries citing papers authored by Chantal Himberlin

Since Specialization
Citations

This map shows the geographic impact of Chantal Himberlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chantal Himberlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chantal Himberlin more than expected).

Fields of papers citing papers by Chantal Himberlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chantal Himberlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chantal Himberlin. The network helps show where Chantal Himberlin may publish in the future.

Co-authorship network of co-authors of Chantal Himberlin

This figure shows the co-authorship network connecting the top 25 collaborators of Chantal Himberlin. A scholar is included among the top collaborators of Chantal Himberlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chantal Himberlin. Chantal Himberlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Michonneau, David, Marie Robin, Flore Sicre de Fontbrune, et al.. (2022). Life expectancy and burden of late complications after reduced intensity conditioning allogeneic transplantation. Bone Marrow Transplantation. 57(9). 1365–1372. 4 indexed citations
3.
Cornillon, Jérôme, Élisabeth Daguenet, Jacques‐Olivier Bay, et al.. (2019). BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC). Annals of Hematology. 98(8). 1973–1980. 1 indexed citations
4.
Sébert, Marie, Raphaël Porcher, Marie Robin, et al.. (2014). Equivalent outcomes using reduced intensity or conventional myeloablative conditioning transplantation for patients aged 35 years and over with AML. Bone Marrow Transplantation. 50(1). 74–81. 16 indexed citations
5.
Robin, Marie, Raphaël Porcher, Lionel Adès, et al.. (2013). Matched unrelated or matched sibling donors result in comparable outcomes after non-myeloablative HSCT in patients with AML or MDS. Bone Marrow Transplantation. 48(10). 1296–1301. 33 indexed citations
6.
Guièze, Romain, Pascale Cornillet‐Lefèbvre, Bruno Lioure, et al.. (2012). Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3‐ITD molecular status for cytogenetically normal AML patients: A GOELAMS study. American Journal of Hematology. 87(12). 1052–1056. 19 indexed citations
8.
Ojeda‐Uribe, Mario, Anne Schneider, Isabelle Luquet, et al.. (2012). Therapy‐related acute myeloid leukemia (t‐AML) with poor‐risk cytogenetics in two patients with persistent molecular complete remission of acute promyelocytic leukemia. European Journal Of Haematology. 89(3). 267–272. 6 indexed citations
9.
Perrot, Aurore, Isabelle Luquet, Arnaud Pigneux, et al.. (2011). Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities. Blood. 118(3). 679–685. 50 indexed citations
10.
Pigneux, Arnaud, Jean‐Luc Harousseau, Francis Witz, et al.. (2010). Addition of Lomustine to Idarubicin and Cytarabine Improves the Outcome of Elderly Patients With De Novo Acute Myeloid Leukemia: A Report From the GOELAMS. Journal of Clinical Oncology. 28(18). 3028–3034. 26 indexed citations
11.
Perrot, Aurore, Isabelle Luquet, Arnaud Pigneux, et al.. (2009). Prognostic Value of the ‘Monosomal Karyotype’ Entity in Elderly Patients with AML: a GOELAMS Study of 186 Patients with Unfavourable Cytogenetic Abnormalities.. Blood. 114(22). 1577–1577. 3 indexed citations
12.
Gardin, Claude, Thomas Prébet, Krimo Bouabdallah, et al.. (2009). A Phase II Study of Post–Remission Therapy with Azacitidine (AZA) in Patients with AML Post-MDS and High-Risk MDS: A GFM Group Study.. Blood. 114(22). 844–844. 7 indexed citations
13.
Papathanassiou, Dimitri, et al.. (2009). Neurolymphomatose du nerf sciatique en TEP au FDG : à propos d’un cas et revue de la littérature. Médecine Nucléaire. 33(12). 768–771.
14.
Hunault, Mathilde, Jean‐Luc Harousseau, Serge Bologna, et al.. (2007). Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial. Haematologica. 92(12). 1623–1630. 25 indexed citations
15.
Harousseau, Jean‐Luc, Norbert Vey, Francis Witz, et al.. (2007). Gentuzumab-Ozogamicin (GO) Plus Idarubicin (I) and Cytarabine (C) as Induction Treatment for Elderly Patients with Poor-Risk Cytogenetics Acute Myeloid Leukemia (AML).. Blood. 110(11). 1839–1839. 3 indexed citations
17.
Tassan‐Mangina, Sophie, Bruno M. Costa, Chantal Himberlin, et al.. (2005). Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: Early and late alterations of left ventricular function during a prospective study. European Journal of Echocardiography. 7(2). 141–146. 171 indexed citations
18.
Hasbini, Ali, et al.. (1997). La méningite carcinomateuse: une complication rare du cancer de la vessie. La Revue de Médecine Interne. 18(5). 402–406. 9 indexed citations
19.
Himberlin, Chantal, Jean‐Claude Mérol, Xavier Panis, et al.. (1996). Prognostic significance of routine clinical and laboratory data in advanced head and neck cancers.. PubMed. 16(2). 1005–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026